Helix BioMedix, Inc., a biopharmaceutical company specializing in peptides, has announced the promotion of Robin L. Carmichael to the position of president. She will retain her title of chief operating officer and continue as a member of the company’s Board of Directors. Carmichael will be responsible for all aspects of management of Helix BioMedix including sales, marketing, business development, pharmaceutical and consumer product programs, skin care brands, research and development and licensing. R. Stephen Beatty who had been serving as president and chief executive officer, will continue to serve as the company’s chief executive officer and has been appointed as chairman of the Board of Directors, a position that was previously vacant.